Arterial Spin-Labeling MR Imaging in the Detection of Intracranial Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia

References

1. 1.↵
   1. Kjeldsen AD,
   2. Vase P,
   3. Green A

   . Hereditary haemorrhagic telangiectasia: a population‐based study of prevalence and mortality in Danish patients. J Intern Med 1999;245:31–9 doi:10.1046/j.1365-2796.1999.00398.x

   CrossRefPubMedWeb of Science
2. 2.↵
   1. McDonald J,
   2. Bayrak-Toydemir P,
   3. Pyeritz RE

   . Hereditary hemorrhagic telangiectasia: an overview of diagnosis, management, and pathogenesis. Genet Med 2011;13:607–16 doi:10.1097/GIM.0b013e3182136d32 pmid:21546842

   CrossRefPubMed
3. 3.↵
   1. Faughnan ME,
   2. Palda VA,
   3. Garcia-Tsao G, et al

   ; HHT Foundation International-Guidelines Working Group. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 2011;48:73–87 doi:10.1136/jmg.2009.069013 pmid:19553198

   Abstract/FREE Full Text
4. 4.↵
   1. Shovlin CL,
   2. Guttmacher AE,
   3. Buscarini E, et al

   . Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66–7 doi:10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P pmid:10751092

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Sautter NB,
   2. Smith TL

   . Hereditary hemorrhagic telangiectasia-related epistaxis: innovations in understanding and management. Int Forum Allergy Rhinol 2012;2:422–31 doi:10.1002/alr.21046 pmid:22566463

   CrossRefPubMed
6. 6.↵
   1. Martín-Noguerol T,
   2. Concepción-Aramendia L,
   3. Lim CT, et al

   . Conventional and advanced MRI evaluation of brain vascular malformations. J Neuroimaging 2021;31:428–45 doi:10.1111/jon.12853 pmid:33856735

   CrossRefPubMed
7. 7.↵
   1. Maher CO,
   2. Piepgras DG,
   3. Brown RD, et al

   . Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 2001;32:877–82 doi:10.1161/01.str.32.4.877 pmid:11283386

   Abstract/FREE Full Text
8. 8.↵
   1. Fulbright RK,
   2. Chaloupka JC,
   3. Putman CM, et al

   . MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol 1998;19:477–84 pmid:9541302

   PubMedWeb of Science
9. 9.↵
   1. Yang W,
   2. Liu A,
   3. Hung AL, et al

   . Lower risk of intracranial arteriovenous malformation hemorrhage in patients with hereditary hemorrhagic telangiectasia. Neurosurgery 2016;78:684–93 doi:10.1227/NEU.0000000000001103 pmid:26540357

   CrossRefPubMed
10. 10.↵
    1. Willemse RB,
    2. Mager JJ,
    3. Westermann CJ, et al

    . Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg 2000;92:779–84 doi:10.3171/jns.2000.92.5.0779 pmid:10794291

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Willinsky RA,
    2. Taylor SM,
    3. TerBrugge K, et al

    . Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology 2003;227:522–28 doi:10.1148/radiol.2272012071 pmid:12637677

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Hetts SW,
    2. Shieh JT,
    3. Ohliger MA, et al

    . Hereditary hemorrhagic telangiectasia: the convergence of genotype, phenotype, and imaging in modern diagnosis and management of a multisystem disease. Radiology 2021;300:17–30 doi:10.1148/radiol.2021203487 pmid:33973836

    CrossRefPubMed
13. 13.↵
    1. Faughnan ME,
    2. Mager JJ,
    3. Hetts SW, et al

    . Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. Ann Intern Med 2020;173:989–1001 doi:10.7326/M20-1443 pmid:32894695

    CrossRefPubMed
14. 14.↵
    1. Vella M,
    2. Alexander MD,
    3. Mabray MC, et al

    . Comparison of MRI, MRA, and DSA for detection of cerebral arteriovenous malformations in hereditary hemorrhagic telangiectasia. AJNR Am J Neuroradiol 2020;41:969–75 doi:10.3174/ajnr.A6549 pmid:32381546

    Abstract/FREE Full Text
15. 15.↵
    1. Petcharunpaisan S,
    2. Ramalho J,
    3. Castillo M

    . Arterial spin labeling in neuroimaging. World J Radiology 2010;2:384–98 doi:10.4329/wjr.v2.i10.384 pmid:21161024

    CrossRefPubMed
16. 16.↵
    1. Deibler AR,
    2. Pollock JM,
    3. Kraft RA, et al

    . Arterial spin-labeling in routine clinical practice, part 1: technique and artifacts. AJNR Am J Neuroradiol 2008;29:1228–34 doi:10.3174/ajnr.A1030 pmid:18372417

    CrossRefPubMed
17. 17.↵
    1. Wolf RL,
    2. Detre JA

    . Clinical neuroimaging using arterial spin-labeled perfusion magnetic resonance imaging. Neurotherapeutics 2007;4:346–59 doi:10.1016/j.nurt.2007.04.005 pmid:17599701

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Petersen ET,
    2. Lim T,
    3. Golay X

    . Model-free arterial spin labeling quantification approach for perfusion MRI. Magn Reson Med 2006;55:219–32 doi:10.1002/mrm.20784 pmid:16416430

    CrossRefPubMed
19. 19.↵
    1. Hodel J,
    2. Leclerc X,
    3. Kalsoum E, et al

    . Intracranial arteriovenous shunting: detection with arterial spin-labeling and susceptibility-weighted imaging combined. AJNR Am J Neuroradiol 2017;38:71–76 doi:10.3174/ajnr.A4961 pmid:27789452

    Abstract/FREE Full Text
20. 20.↵
    1. Lindner T,
    2. Bolar DS,
    3. Achten E, et al

    ; on behalf of the ISMRM Perfusion Study Group. Current state and guidance on arterial spin labeling perfusion MRI in clinical neuroimaging. Magn Reson Med 2023;89:2024–47 doi:10.1002/mrm.29572 pmid:36695294

    CrossRefPubMed
21. 21.↵
    1. Berg J,
    2. Porteous M,
    3. Reinhardt D, et al

    . Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet 2003;40:585–90 doi:10.1136/jmg.40.8.585 pmid:12920067

    Abstract/FREE Full Text
22. 22.↵
    1. Plauchu H,
    2. de Chadarévian JP,
    3. Bideau A, et al

    . Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989;32:291–97 doi:10.1002/ajmg.1320320302 pmid:2729347

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Porteous ME,
    2. Burn J,
    3. Proctor SJ

    . Hereditary haemorrhagic telangiectasia: a clinical analysis. J Med Genet 1992;29:527–30 doi:10.1136/jmg.29.8.527 pmid:1518020

    Abstract/FREE Full Text
24. 24.↵
    1. Le TT,
    2. Fischbein NJ,
    3. André JB, et al

    . Identification of venous signal on arterial spin labeling improves diagnosis of dural arteriovenous fistulas and small arteriovenous malformations. AJNR Am J Neuroradiol 2012;33:61–68 doi:10.3174/ajnr.A2761 pmid:22158927

    Abstract/FREE Full Text
25. 25.↵
    1. Mayercik V,
    2. Taiwo R,
    3. Marks M, et al

    . O-023 Arterial spin labeling (ASL) MRI assists in identification of cerebral micro-arteriovenous malformations. J Neurointerv Surg 2021;13:A16

    Abstract/FREE Full Text
26. 26.↵
    1. Grade M,
    2. Hernandez Tamames JA,
    3. Pizzini FB, et al

    . A neuroradiologist’s guide to arterial spin labeling MRI in clinical practice. Neuroradiology 2015;57:1181–202 doi:10.1007/s00234-015-1571-z pmid:26351201

    CrossRefPubMed
27. 27.↵
    1. Shimoda Y,
    2. Osanai T,
    3. Nakayama N, et al

    . De novo arteriovenous malformation in a patient with hereditary hemorrhagic telangiectasia. J Neurosurg Pediatr 2016;17:330–35 doi:10.3171/2015.7.PEDS15245 pmid:26613274

    CrossRefPubMed
28. 28.↵
    1. Alsop DC,
    2. Detre JA,
    3. Golay X, et al

    . Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM Perfusion Study Group and the European Consortium for ASL in Dementia. Magn Reson Med 2015;73:102–16 doi:10.1002/mrm.25197 pmid:24715426

    CrossRefPubMed